Cargando…

Systematic construction and validation of an immune prognostic model for lung adenocarcinoma

Lung adenocarcinoma (LUAD), the most common non‐small‐cell lung cancer, is characterized by a dense lymphocytic infiltrate, which indicates that the immune system plays an active role in the development and growth of this cancer. However, no investigations to date have proposed robust models for pre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luo, Chenghan, Lei, Mengyuan, Zhang, Yixia, Zhang, Qian, Li, Lifeng, Lian, Jingyao, Liu, Shasha, Wang, Liping, Pi, Guofu, Zhang, Yi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6991688/ https://www.ncbi.nlm.nih.gov/pubmed/31779055 http://dx.doi.org/10.1111/jcmm.14719

Ejemplares similares

Congenital Myasthenic Syndrome Caused by a Novel Hemizygous CHAT Mutation
por: Zhang, Yixia, et al.
Publicado: (2020)

Development and Validation of a Nomogram for Predicting Bronchopulmonary Dysplasia in Very-Low-Birth-Weight Infants
por: Zhang, Jingdi, et al.
Publicado: (2021)

Construction and Validation of a Novel Immune-Related Gene Pairs-Based Prognostic Model in Lung Adenocarcinoma
por: Liu, Yafeng, et al.
Publicado: (2023)

Construction and validation of an angiogenesis-related lncRNA prognostic model in lung adenocarcinoma
por: Gong, Quan, et al.
Publicado: (2023)

Construction and validation of a novel ferroptosis-related prognostic signature for lung adenocarcinoma
por: Yang, Li, et al.
Publicado: (2023)

Identification and validation of a necroptosis-related gene prognostic signature for colon adenocarcinoma
por: Zhang, Jingyao, et al.
Publicado: (2023)

Hypoxia Constructing the Prognostic Model of Colorectal Adenocarcinoma and Related to the Immune Microenvironment
por: Zhang, Yuanyuan, et al.
Publicado: (2021)

Development and validation of an immune‐related prognostic signature in lung adenocarcinoma
por: Sun, Sijin, et al.
Publicado: (2020)

Development and Validation of a Dynamic Nomogram to Predict the Risk of Neonatal White Matter Damage
por: Cao, Wenjun, et al.
Publicado: (2021)

Construction and validation of an immunity-related prognostic signature for breast cancer
por: Zhu, Tao, et al.
Publicado: (2020)

The Relationship Between Cord Blood Cytokine Levels and Perinatal Characteristics and Bronchopulmonary Dysplasia: A Case–Control Study
por: Wang, Mengmeng, et al.
Publicado: (2022)

Construction of a Prognostic Immune-Related LncRNA Risk Model for Lung Adenocarcinoma
por: Li, Yue, et al.
Publicado: (2021)

Construction and Validation of an Immune-Based Prognostic Model for Pancreatic Adenocarcinoma Based on Public Databases
por: Mao, Miaobin, et al.
Publicado: (2021)

Lung adenocarcinoma-intrinsic GBE1 signaling inhibits anti-tumor immunity
por: Li, Lifeng, et al.
Publicado: (2019)

Construction of an STK11 Mutation and Immune-Related Prognostic Prediction Model in Lung Adenocarcinoma
por: Tang, Bo, et al.
Publicado: (2023)

Construction and validation of a novel prognostic signature of microRNAs in lung adenocarcinoma
por: Li, Wanzhen, et al.
Publicado: (2021)

Construction of the optimization prognostic model based on differentially expressed immune genes of lung adenocarcinoma
por: Zhai, Yang, et al.
Publicado: (2021)

Construction of immune-related and prognostic lncRNA clusters and identification of their immune and genomic alterations characteristics in lung adenocarcinoma samples
por: Li, Jia, et al.
Publicado: (2020)

Development and Validation of a Combined Hypoxia and Immune Prognostic Classifier for Lung Adenocarcinoma
por: Huang, Hua, et al.
Publicado: (2022)

Analysis of potential biomarkers and immune infiltration in autism based on bioinformatics analysis
por: Cao, Wenjun, et al.
Publicado: (2023)

Identification of New Prognostic Genes and Construction of a Prognostic Model for Lung Adenocarcinoma
por: Chen, Xueping, et al.
Publicado: (2023)

Development and validation of a combined metabolism and immune prognostic model in lung adenocarcinoma
por: Shi, Yu, et al.
Publicado: (2022)

Identification and Validation of Immune-Related LncRNA Prognostic Signature for Lung Adenocarcinoma
por: Wu, Guomin, et al.
Publicado: (2021)

Regulation of early diagnosis and prognostic markers of lung adenocarcinoma in immunity and hypoxia
por: Sun, Kang, et al.
Publicado: (2023)

Hypoxia-induced GBE1 expression promotes tumor progression through metabolic reprogramming in lung adenocarcinoma
por: Li, Lifeng, et al.
Publicado: (2020)

Profiles of Immune Infiltration and Prognostic Immunoscore in Lung Adenocarcinoma
por: Li, Yanyan, et al.
Publicado: (2020)

Construction of Lymph Node Metastasis-Related Prognostic Model and Analysis of Immune Infiltration Mode in Lung Adenocarcinoma
por: Li, Wujin, et al.
Publicado: (2022)

Development and validation of a prognostic risk signature for lung adenocarcinoma constructed by six ferroptosis, necroptosis, and pyroptosis-related lncRNAs
por: Peng, Lei, et al.
Publicado: (2022)

Interleukin‐33‐nuclear factor‐κB‐CCL2 signaling pathway promotes progression of esophageal squamous cell carcinoma by directing regulatory T cells
por: Yue, Ying, et al.
Publicado: (2020)

Identification and Validation of a GPX4-Related Immune Prognostic Signature for Lung Adenocarcinoma
por: Feng, Zhenxing, et al.
Publicado: (2022)

Development and Validation of a Prognostic N6-Methyladenosine-Related Immune Gene Signature for Lung Adenocarcinoma
por: Zhang, Lemeng, et al.
Publicado: (2021)

Construction of a circRNA-Related Prognostic Risk Score Model for Predicting the Immune Landscape of Lung Adenocarcinoma
por: Li, Huawei, et al.
Publicado: (2021)

A Good Way to Reduce Screening for Retinopathy of Prematurity: Development of the ROP Model in a China Preterm Population
por: Ding, Wenqian, et al.
Publicado: (2021)

Construction and comprehensive analysis of a ceRNA network to reveal potential prognostic biomarkers for lung adenocarcinoma
por: Gao, Lei, et al.
Publicado: (2021)

Construction and Comprehensive Analyses of a METTL5-Associated Prognostic Signature With Immune Implication in Lung Adenocarcinomas
por: Sun, Sijin, et al.
Publicado: (2021)

Construction and validation of a novel prognostic model of neutrophil‑related genes signature of lung adenocarcinoma
por: Zhu, Qianjun, et al.
Publicado: (2023)

Bioinformatics construction and experimental validation of a cuproptosis-related lncRNA prognostic model in lung adenocarcinoma for immunotherapy response prediction
por: Li, Linfeng, et al.
Publicado: (2023)

Construction of subtype classifiers and validation of a prognostic risk model based on hypoxia-associated lncRNAs for lung adenocarcinoma
por: Hui, Hongliang, et al.
Publicado: (2023)

An individualized immune prognostic signature in lung adenocarcinoma
por: Sun, Liangdong, et al.
Publicado: (2020)

Construction and validation of a novel prognostic nomogram for predicting overall survival in lung adenocarcinoma patients with different patterns of metastasis
por: Xiong, Ying, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8deqms7iur6e981l541hqieq4u